Cryoport vs Maravai Lifesciences Holdings
Cryoport and Maravai Lifesciences Holdings are similar in size: $176m and $186m of revenue in their latest fiscal years. Cryoport grew faster (12.4% against -28.3%). Cryoport kept more of each dollar of sales as profit: a net margin of 44.4% against -70.4%. Cryoport carries less debt relative to equity (37.1% against 138.5%).
| Latest fiscal year | CryoportCYRX, 2025 | Maravai Lifesciences HoldingsMRVI, 2025 |
|---|---|---|
| Revenue | $176m | $186m |
| Revenue growth | 12.4% | -28.3% |
| Net income | $78.3m | −$131m |
| Operating margin | -20.9% | -115.9% |
| Net margin | 44.4% | -70.4% |
| Return on equity | 17.3% | -48.6% |
| Free cash flow | −$25.0m | −$70.7m |
| Cash | $250m | $217m |
| Total debt | $186m | $294m |
| Debt to equity | 37.1% | 138.5% |
| Dividend per share | — | — |
| Dividend yield | — | — |
| Share buybacks | $10.0m | — |
| Employees | 738 | 435 |
| Market value | $844m | $1.11bn |
| Price vs our value range | — | — |
| Moat score | 19 (Weak) | 23 (Weak) |
| Insider trades, 12 months | 0 buys, 14 sales | 5 buys, 2 sales |